PolyMedix Inc (OTC Pink - Limited Information:PYMXQ)
| 0.25 Data as of Jun 19 |  -0.03 / -10.71%Today’s Change | 0.06 Today|||52-Week Range 18.50 | -97.06% Year-to-Date |
Latest PYMXQ News | Press Releases
No recent news for PolyMedix Inc.
Today’s Trading
| Previous close | 0.28 |
| Today’s open | 0.28 |
| Day’s range | -- - -- |
| Volume | 101,876 |
| Average volume (3 months) | 35,374 |
| Market cap | -- |
| Dividend yield | -- |
Data as of 2:08pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | +98.60% |
| Earnings growth (this year) | +50.00% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -4.15% |
| P/E ratio | NM |
| Price/Sales | 384.82 |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Last reporting date | June 20, 2013 |
| EPS forecast (this quarter) | -$1.50 |
| Annual revenue (last year) | $2.4M |
| Annual profit (last year) | -$15.4M |
| Net profit margin | -652.02% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, CEO, CFO, Secretary, CAO & VP Edward F. Smith, CPA |
Chief Medical Officer & SVP-Clinical Development Daniel M. Jorgensen, MD, MBA |
Corporate headquarters Radnor, Pennsylvania |
Forecasts
